Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: LRY002
MIFTS: 20

Laryngostenosis

Categories: Oral diseases, Respiratory diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Laryngostenosis

About this section

MalaCards integrated aliases for Laryngostenosis:

Name: Laryngostenosis 12 45 15 74
Stenosis of Larynx 12

Classifications:

MalaCards categories:
Anatomical: Respiratory diseases Oral diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:11527
ICD9CM 36 478.74
MeSH 45 D007829
NCIt 51 C79608
SNOMED-CT 69 75547007
ICD10 34 J38.6
UMLS 74 C0023075
Sources

Summaries for Laryngostenosis

About this section
MalaCards based summary : Laryngostenosis, also known as stenosis of larynx, is related to diphtheria. An important gene associated with Laryngostenosis is FOXL2 (Forkhead Box L2). The drugs rituximab and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include trachea.

Sources

Related Diseases for Laryngostenosis

About this section

Diseases related to Laryngostenosis via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 diphtheria 9.8

Comorbidity relations with Laryngostenosis via Phenotypic Disease Network (PDN):


Bronchitis Heart Disease
Hypertension, Essential Respiratory Failure
Sources

Symptoms & Phenotypes for Laryngostenosis

About this section
Sources

Drugs & Therapeutics for Laryngostenosis

About this section

Drugs for Laryngostenosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
rituximab Approved Phase 3 174722-31-7 10201696
2
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
3 Alkylating Agents Phase 3,Not Applicable
4 Immunologic Factors Phase 3
5 Immunosuppressive Agents Phase 3
6 Antirheumatic Agents Phase 3
7 Antineoplastic Agents, Alkylating Phase 3
8 Antineoplastic Agents, Immunological Phase 3
9
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
10
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
11
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
12
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
13
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7
14 Antineoplastic Agents, Hormonal Phase 2
15 Peripheral Nervous System Agents Phase 2
16 Gastrointestinal Agents Phase 2
17 Neuroprotective Agents Phase 2
18 Hormones Phase 2
19 Antiemetics Phase 2
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
21 Autonomic Agents Phase 2
22 Methylprednisolone Acetate Phase 2
23 glucocorticoids Phase 2
24 Protective Agents Phase 2
25 Anti-Inflammatory Agents Phase 2
26 Prednisolone acetate Phase 2
27 Hormone Antagonists Phase 2
28
Olaparib Approved Phase 1 763113-22-0 23725625
29 Poly(ADP-ribose) Polymerase Inhibitors Phase 1
30
Temazepam Approved, Investigational Not Applicable 846-50-4 5391
31 Nucleic Acid Synthesis Inhibitors Not Applicable
32 Antibiotics, Antitubercular Not Applicable
33 Anti-Bacterial Agents Not Applicable
34 Mitomycins Not Applicable

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid Not yet recruiting NCT03295383 Phase 3 Rituximab 1g IV;Cyclophosphamide 50Mg Oral Tablet;Placebo of Rituximab;Placebo Oral Tablet
2 Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells Active, not recruiting NCT03130374 Phase 1, Phase 2
3 Corticosteroid Treatment in the Acute Phase of Caustic Ingestion Management Not yet recruiting NCT03760354 Phase 2 Methylprednisolone
4 Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants Withdrawn NCT01977911 Phase 1, Phase 2
5 Olaparib and Radiotherapy in Head and Neck Cancer Recruiting NCT02229656 Phase 1 Olaparib
6 Functional Modeling of the Pediatric Airway Completed NCT01690078
7 Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence Recruiting NCT03423017 Not Applicable
8 Treatment Alternatives in iSGS (NoAAC PR-02 Study) Active, not recruiting NCT02481817
9 Laryngeal Allograft Transplantation Enrolling by invitation NCT03269396 Not Applicable
10 Study of Mitomycin-C Application in Laryngotracheal Stenosis Terminated NCT01523275 Not Applicable Mitomycin -C

Search NIH Clinical Center for Laryngostenosis

Cochrane evidence based reviews: laryngostenosis

Sources

Genetic Tests for Laryngostenosis

About this section
Sources

Anatomical Context for Laryngostenosis

About this section

MalaCards organs/tissues related to Laryngostenosis:

42
Trachea
Sources

Publications for Laryngostenosis

About this section

Articles related to Laryngostenosis:

# Title Authors Year
1
Severe feeding problems and congenital laryngostenosis in a patient with 3q23 deletion. ( 9266197 )
1997
2
Mechanical appliance for cicatricial stenosis of larynx and upper part of trachea; report of case. ( 13363239 )
1956
3
Mechanical appliance for cicatricial stenosis of larynx and upper part of trachea; report of case. ( 13422506 )
1956
4
Three cases of congenital laryngostenosis with different etiologies. ( 18885519 )
1948
5
Stenosis of Larynx due to Lupus, now being treated by Progressive Dilatation. ( 19988356 )
1931
6
OPERATIVE RELIEF OF LARYNGOSTENOSIS. ( 17865603 )
1927
7
Stenosis of Larynx. ( 19975933 )
1912
8
Complete Stenosis of Larynx left after Diphtheria and Tracheotomy, in a Boy when aged 1 year and 2 months; completely cured by Repeated Intubations spread over Three Years. ( 19974419 )
1910
9
Stenosis of Larynx in a Child. ( 19973689 )
1909
Sources

Variations for Laryngostenosis

About this section
Sources

Expression for Laryngostenosis

About this section
Search GEO for disease gene expression data for Laryngostenosis.
Sources

Pathways for Laryngostenosis

About this section
Sources

GO Terms for Laryngostenosis

About this section
Sources

Sources for Laryngostenosis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....